Organisation
EACH is overseen by the EACH Executive Committee.
The EACH Advisory Committee is made up of representatives from EACH member countries and gives input on EACH activities locally and internationally.
The EACH Networking Committee facilitates networks, both within countries and within disciplines to coordinate their efforts and act together to achieve results for a whole community of healthcare communicators.
EACH works across three broad areas, overseen by our major committees:
Running alongside the core committees, Special Interest Groups (SIGs) allow members with similar
interests in a specific subject area to meet and collaborate.
In addition, yEACH provides a networking and support group for early-career EACH members.
Charity
EACH: International Association for Communication in Healthcare was established in 2001 and has achieved charitable status. The charity’s purpose is “the relief of sickness and the preservation of health of patients by the promotion of effective evidence-based patient-centred healthcare communication between patients, relatives and healthcare practitioners throughout the world”.
National Representatives from countries with more than 5 members are eligible to be Trustees of the charity, and also sit on the Advisory Committee.
In all of its activities within its charitable specialised network, EACH respects and promotes the fundamental value of transparency. Please click here for details regarding our Position Statement on Transparency.
Registered charity number 1159050. Click here to view details held by the UK Charity Commission and here to read our constitution. Click here to view EACH’s charity registration certificate.
Funding
Funding for the charity’s core activities and projects come from charitable and voluntary donations, membership fees, conferences, courses, and a guaranteed royalty from our publication partner, Elsevier. Many of EACH’s activities are also supported by contributions in kind.
To prevent any potential conflict of interest, EACH has an agreed policy not to accept funding from the pharmaceutical industry for any of its activities.